J Clin Aesthet Dermatol. 2024;17(11-12 Suppl 1):S19–27. Acne Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel
J Clin Aesthet Dermatol. 2024;17(11–12 Suppl 1):S28 by Kasey D’Amato, PA-C, MPAP, and Kathryn Werner, PA-C Ms. D’Amato is President
J Clin Aesthet Dermatol. 2024;17(11–12 Suppl 1):S30–S33. by Miguel A. Aristizabal, MD; Tara Soto, PA-C; Leila Tolaymat, MD; and Alison
by Archana M. Sangha, MMS, PA-C Ms. Sangha is a senior medical science liaison for Incyte Corporation in Wilmington, Delaware.
by Kathryn Harrison DMSc, MMS, PA-C, CAQ-Dermatology Dr. Harrison is with Forefront Dermatology in Englewood, Colorado, and is a Diplomat
By Erin Hennessey, DNP, APRN, FNP-C Ms. Hennessey is the Owner of Blush Aesthetics in Perrysburg and Toledo, Ohio, and
by Douglas DiRuggiero, DMSc, PA-C; Cynthia Trickett, PA-C, MPAS; Lauren Hippeli, MS; Sang Hee Park, MPH; Amy Baum-Jones, MPAS, PA-C;
J Clin Aesthet Dermatol. 2024;17(7–8 Suppl 1):S27–S36. Acne Efficacy and safety of fixed-dose clindamycin phosphate 1.2%/adapalene 0.15%/benzoyl peroxide 3.1% gel
by Archana M. Sangha, MMS, PA-C Ms. Sangha is a senior medical science liaison for Incyte Corporation in Wilmington, Delaware.
